Evidence map›Paper›PMID 39204529›Full record

ReviewPolymers2024

Polymers Containing Phenothiazine, Either as a Dopant or as Part of Their Structure, for Dye-Sensitized and Bulk Heterojunction Solar Cells.

Muhammad Faisal Amin, Amna Anwar, Paweł Gnida, Bożena Jarząbek

Abstract readReview
In one paragraph

Review in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Muhammad Faisal AminCentre of Polymer and Carbon Materials, Polish Academy of Sciences, 34 M. Curie-Sklodowska Str., 41-819 Zabrze, Poland.
Amna AnwarDepartment of Chemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan.
Paweł GnidaCentre of Polymer and Carbon Materials, Polish Academy of Sciences, 34 M. Curie-Sklodowska Str., 41-819 Zabrze, Poland.ORCID 0000-0003-3350-9383
Bożena JarząbekCentre of Polymer and Carbon Materials, Polish Academy of Sciences, 34 M. Curie-Sklodowska Str., 41-819 Zabrze, Poland.ORCID 0000-0002-2539-0768

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Potential photovoltaic technology includes the newly developed dye-sensitized solar cells (DSSCs) and bulk heterojunction (BHJ) solar cells. Owing to their diverse qualities, polymers can be employed in third-generation photovoltaic cells to specifically alter their device elements and frameworks. Polymers containing phenothiazine, either as a part of their structure or as a dopant, are easy and economical to synthesize, are soluble in common organic solvents, and have the potential to acquire desired electrochemical and photophysical properties by mere tuning of their chemical structures. Such polymers have therefore been used either as photosensitizers in dye-sensitized solar cells, where they have produced power conversion efficiency (PCE) values as high as 5.30%, or as donor or acceptor materials in bulk heterojunction solar cells. Furthermore, they have been employed to prepare liquid-free polymer electrolytes for dye-sensitized and bulk heterojunction solar cells, producing a PCE of 8.5% in the case of DSSCs. This paper reviews and analyzes almost all research works published to date on phenothiazine-based polymers and their uses in dye-sensitized and bulk heterojunction solar cells. The impacts of their structure and molecular weight and the amount when used as a dopant in other polymers on the absorption, photoluminescence, energy levels of frontier orbitals, and, finally, photovoltaic parameters are reviewed. The advantages of phenothiazine polymers for solar cells, the difficulties in their actual implementation and potential remedies are also evaluated.

Indexed as

bulk heterojunction solar cellsdye-sensitized solar cellsphenothiazinephotovoltaic parameterspolymers

Identifiers

PMID39204529
PMCPMC11360421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.